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aetiopathogenesis and clinical manifestations
of multiple sclerosis?
Bernd Krone1,2*† and John M Grange3†Abstract
Background: Multiple sclerosis (MS) has undergone a significant increase in incidence in the industrialised nations
over the last 130 years. Changing environmental factors, possibly infections or a lack of or altered timing of them,
determine the prevalence of the disease. Although a plethora of aetiological factors, clearly evident in a group of
children with MS, appear relevant, there may nevertheless be a single factor essential for the aetiopathogenesis and
clinical manifestation of MS.
Description and discussion: This hitherto unknown factor is postulated to be a ‘melanoma-like neuromelanin’
(MLN) dependent on the activation of a gene for syncytin-1. An involvement of MLN could explain the diverse
findings in the epidemiology, immunology and pathology of MS, requiring a consideration of a complex infectious
background, the human leucocyte antigens, as well as cosmic radiation causing geomagnetic disturbances, vitamin
D deficiency, smoking, and lower levels of uric acid.
Summary: In principle, the MLN-based concept is a unifying one, capable of explaining a number of characteristics
of the disease. To date, MLN has not been addressed in studies on MS and future work will need to be done on
human patients, as there is little or no neuromelanin (the precursor of MLN) in the animals used as experimental
models in the study of MS.
Keywords: Multiple sclerosis, Risk factors, Latency, Melanoma, Neuro-melanin, Epstein-Barr virus, Human
endogenous retrovirus, Vitamin D, Geomagnetic disturbancesBackground
The recent paper by Sajedi and Abdollahi in this journal
[1] on geomagnetic disturbances as a risk factor for mul-
tiple sclerosis (MS) emphasises the complexity of the
pathogenesis of this disease but also encourages a search
for an underlying factor that could be affected by such
disturbances and other risk factors. A recent broad-
ranging epidemiologic study also focuses attention on
the aetiology of multiple sclerosis and facilitates a* Correspondence: bernd-krone@t-online.de
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distribution, and reproduction in any mediumreappraisal of the putative risk factors [2]. The outstand-
ing question is whether, among the plethora of described
possible aetiological factors for MS, there is a single,
hitherto undescribed, risk factor that is essential for the
entire course of the disease process from the initiating
events to clinical manifestation.Aim of the debate
In response to this issue, we emphasise that the complex
epidemiology does indeed point to a plethora of con-
comitant factors in MS. Moreover, further enigmas, in
particular the wide variation in age of onset and the oc-
currence of latency and relapses require, for their ex-
planation, an endogenous underlying risk factor essential
for the pathogenesis and clinical manifestation of theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.biomedcentral.com/1471-2377/13/91disease. In this paper we propose one such putative
factor, a ‘melanoma-like neuromelanin’ (MLN), the in-
volvement of which is supported by the available epi-
demiological data, and we discuss the relevance of this
factor to the interpretation of past and current studies
on MS and on the possible direction of future studies.
The many factors postulated to play a role in the aeti-
ology of MS are summarised in Table 1, according to the
strength of the evidence. The candidate factors with pos-
sible relevance in MS will be considered only in relation
to MLN. Alternative and/or additional influences of
these factors [3] are included in Table 1 but are largely
beyond the scope of this debate.
It is, however, important to note that the quality of the
evidence for the relevance of the many described factors
to the pathogenesis and clinical outcome of MS varies
considerably. To guide the reader, we make clear in the
Table 1 those observations that are supported by firm
evidence. All interpretations in the text beyond the
section ‘Evidence for concomitant effects’ are only
speculative but, again, those considered to be of key
relevance for the proposed unifying concept are likewise
highlighted (●●● = very relevant and ●● = relevant).
Evidence for concomitant effects
An illustrative group of paediatric patients studied by
Hanefeld and co-workers [10,15,17,18] emphasises the wide
range of factors of putative relevance in the pathogenesis of
MS (Table 1, footnote §). The most notable of these are evi-
dence of past infection with Epstein-Barr virus (EBV) in vir-
tually all patients [10,60] ●●●, and altered immune
responses to infections with several other viruses, in par-
ticular with measles, varicella, and herpes simplex viruses
[15] ●●●, and with Chlamydia pneumoniae [15,20]. More-
over, production of specific antibody against measles, ru-
bella, varicella, EBV and herpes simplex viruses in the
brain/cerebrospinal fluid is also a hallmark of MS [17,18]
●●. Further observations reveal an association of MS risk
with the season of birth, postulated to be related to low
vitamin D levels experienced in utero (pre-birth) [19,30],
exposure to visible light close to the time of onset of the
disease [31,51] and, finally, a dependence of MS risk on fe-
male sex hormones that commences only in late childhood,
becoming more pronounced in adolescence, and reaching
maximal values in adults: with the girl:boy ratio on age at
onset in young children (< 8 years) being 1.2:1, compared
with 3:1 in adults [31,32]. The described risk factors for
MS, observed in parallel and numbering around 16, are
listed in Table 1, footnote §.
Is a melanoma-like neuromelanin (MLN) the ‘missing link’?
Current explanations as to how the diverse risk factors
might cooperate to cause MS [3], fail to delineate any
single candidate factor able to explain concomitance offactors operating at widely differing points or periods of
time in life. There is, however, one – though still hypothet-
ical – factor that is in principle able to form the basis of
such time-spanning concomitance and we have already
speculated that this is the ‘missing link’; namely, a
melanoma-like neuromelanin (MLN) [14], and this is sup-
ported by the fact that the initiating steps in MS as well as
in melanoma [61] occur in cells derived from the neural
crest. This encouraged us to seek for parallels in the aeti-
ology of the two diseases, parallels that might be ascribed
to the biosynthesis and action of a hypothetical melanoma-
like neuromelanin. In both diseases various environmental
causative agents have been implicated in pathogenesis and
some may combine, perhaps synergistically, to produce the
respective disease. These include an overexpression of
genes coding for the envelope proteins of human endogen-
ous retroviruses (HERVs), of group W in MS [4-8] and of K
in melanoma [62], although the increased amount of the
HERV-W ENV protein (syncytin-1) in nerve tissue is nei-
ther a genetically determined risk nor a result of an infec-
tious behavior of these elements with a viral ancestry,
encoded by the human genome.
The importance of the establishment of protective im-
munoregulatory surveillance networks for the preven-
tion of MS is emphasised by the so-called hygiene
hypothesis. There is growing evidence from many
sources that environmental factors in the industrialised
nations that isolate the human population from contact
with exogenous viral, microbial and parasitic stimuli that
millions of years of evolution have led the immune
system to ‘expect’ has led to a failure in the development
of immunoregulatory networks and to an increase in
incidence of several classes of disease characterised by
chronic inflammation and autoimmune phenomena
[61,63]. With particular relevance to MS, exposure to
certain pathogens such as the Epstein-Barr virus which
once regularly occurred in infancy now often occurs
only years later [10,12].
In the following sections we discuss the possible
aetiological role of the hypothetical MLN, drawing paral-
lels with melanoma, and the putative role of HERVs,
Epstein-Barr virus, other infections and other non-
infectious environmental factors [3,33] that could affect
the biosynthesis of MLN, possibly commencing even be-
fore birth. We also discuss its subsequent oxidative char-
ging and discharging and its relationship to other
described co-factors acting at quite different times in life
that might also be involved throughout the pathological
processes that finally determine the clinical manifestations
of MS.
Characterization of MLN
Neuromelanins behave as quasi-polymeric redox-pigments
[42]. Relatively large quantities are necessary for chemical
Table 1 Environmental and genetic risk factors for multiple sclerosis
MS risk factor Risk* Observations Postulated mechanism Alternative mechanism
1. Compromise of MS-protective




X F HERV-W and/or syncytin-1 more
frequently detectable/elevated in
MS, increased levels of antibodies
against HERV GAG and ENV
antigens in MS, related to the
activity of disease [4-8]
Overexpression of the syncytin-1
gene encoded by HERV-W disturbs
redox regulation in glial cells [9]
Time in life of infection E●●● P Virtually all MS patients experienced
previous EBV-infection and had
elevated levels of anti- EBV-EBNA1
antibody in comparison with
control groups [3,10,11]. Previous
EBV-infection years or decade(s)
before onset of MS [12]. Expanded
T-helper cell populations
recognizing an epitope of the EBV
antigen EBNA1 in MS patients [13]
Infection with EBV early in life can
establish MS protective immunity
[3,10,11,14]. Infection with EBV
delayed in life after immune
response against an epitope nested
in FENIAEGLRALLARSHVER (partial
sequence of EBNA-1) is primed (see
next entry) to form T- helper cells
instead of regulatory T-cells
essential for MS protection [14]
(Irrespective of time in life):
Clonal expansion of lymphocytes








with measles, varicella and
herpes simplex viruses and
with 12 or more other
pathogens
E●●● P Higher antibody-levels against
diverse pathogens in particular
measles, varicella, herpes simplex
viruses, and EBV in MS-patients
[10,15,16], intrathecal synthesis of
antibodies against these viruses
(including as in particular also
rubella virus) [17,18]
Immune responses against diverse
agents generates MS-protection by
cross-reaction of a self-specific CD8
+-T-cell response against a peptide
MPVPSAPSTMPVPSAPST belonging
to the human endogenous
retrovirus W (HERV-W), encoded on
the complementary DNA-strand of








E § F More frequent detection of
genomes of these agents in MS
[15,20,21] More frequent IgM-
specific antibodies against
Chlamydia pneumoniae in paediatric
onset MS [15]
Persisting infections can prime
immune response against an
epitope nested in
FENIAEGLRALLARSHVER (partial
sequence of EBV EBNA-1) to induce
T-helper cells [14]
Worm infestation E●● P Worm infestation less frequent in
MS and treatment of worm
infections leads to relapse of
MS [22]
Contributes an immune stimulatory
context that favours the generation
of regulatory T-cells






HLA-polymorphism G P Main HLA class I molecule A*0201
for the HLA-A0201 associated with
a significantly reduced MS risk (OR
= 0.52, P = 0.0015) [24]
Ability of HLA-polymorphism for
immune presentation of the
peptide MPVPSAPSTMPVPSAPST is
good such as with HLA-A0201





G P Mutations in IL-2Rα gene in MS
more frequent [25]
Component of the CD-25 molecule
of regulatory T-cells, critical




G P Mutations in IL-7Rα gene in MS
more frequent [26]
Important for maintenance of





E P Reduced MS risk with diet rich in n-3
poly-unsaturated fatty acids [27]
Dietary factors leading to an
enrichment of ganglioside-content
of T-cells. The MS-protective
immune reaction seems to be an
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Table 1 Environmental and genetic risk factors for multiple sclerosis (Continued)
immune repair mediated by
gangliosides [14,19,28,29]
2. Factors favouring the
biosynthesis of MLN not
predominantly involving the
immune system
Vitamin D-deficiency E●●●§ F Month of birth-effect [30,31]. Low
levels of vitamin D in MS patients
[32-34]
Deficiency pre-birth and after birth
reduces intracellular glutathione
[35]
Levels of vitamin D experienced
in utero can have long-lasting
effects on the development of
numerous organ systems,
including the CNS; during life,
vitamin D has clear
immunomodulatory functions
Low sun exposure E●● F Influence of place of residence, MS
risk increases with higher latitude
[3,32]
Reduced exposure to sunlight rich
in UV-B dependent on geographical
latitude [3,32]
Selenium deficiency E w F MS more frequent in regions with
low levels of selenium in soil [36,37]
Selenium deficiency reduces levels
of the seleno-enzyme glutathione-
peroxidase [38]
Female sex hormones E § F Dependence of MS risk on gender.
MS risk in young children
indepedent from gender but
increased girl/boy rate in puberty
[31,32]. Reduced MS risk in
pregnancy, elevated MS risk after
pregnancy and after the
menopause [39]
Syncytin-1 gene has a sensitivity for
female sex hormones, (gene




Smoking E●● F Higher risk of MS in cigarette
smokers [40]
Nicotine accumulates in melanin
containing cells and interferes with
melanin synthesis [41]
Nitric oxide-mediated
demyelination, axonal loss and
epigenetic effects
Iron-load E F MS association to eating of meat




3. Oxidative charging of MLN
Vitamin D-deficiency E●●● F See above See above, glutathione is needed
for discharging of MLN
§
Low sun exposure E●● F See above See above, glutathione is needed
for discharging of MLN
Selenium deficiency E w F See above See above, glutathione-peroxidase
is needed for discharging of MLN
Iron containing MLN is charged by




E●● F MS relates to geomagnetic 60°
latitude [1]
E F MS association to mountain regions
[50]
4. Physiological influence on
activity of neuromelanin
Visible light E § P Increased risk of MS onset (1st
attack) in the lightest months of the
year [31,51]
The hormone melatonin regulates
the daily activity of neuromelanins
(light-triggered day-night rhythm)
5. Formation of short living
reactive oxygen species and
radicals (ROS) by mitochondria
Psycho-physical trauma E F Increased MS risk in relations to
psycho-physical trauma, detection
of ROS-related products in MS [52]
Traumatic events lead to the




Heat/fever E F Heat as attack provoking factor in
MS [53,54]
Heat leads to the generation of ROS
by mitochondria
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E F
MS protective effect of the
introduction of anti-pyretics [53]
and of the antibiotic penicillin [55]
Fever leads to the generation of
ROS by mitochondria
Chronic stress reaction E w F Decreased ubiquinone, and
increased endogenous digoxin and
metabolites of oxidative stress in
MS [56]
Over-activation of the cellular
mevalonate pathway with decrease
of ubiquinone, and increase of
endogenous digoxin and ROS
production by mitochondria [56]
As above
6. Formation of long-living
reactive oxygen species and
radicals (ROS) requiring typically
nitrogen oxide as a co-substrate
Infection/Inflammation E F A small blood vessel is often
running through the plaque, the
end stage of MS pathology [57]
Adherent polymorph nuclear cells
in small blood vessels form
nitrogen oxide (NO) that is not
readily cleared
Gout E P MS is extremely rare in patients
with gout and levels of uric acid are
about 10 to 15% lower in patients
with MS [58]
Radical scavenger function of uric
acid for nitrogen-containing ROS
[58]decreased uric acid E F
Glatiramer-acetate E P An agent with therapeutic benefit
in MS
Inhibition of NO synthase of
mononuclear cells [59]
Categorization of risks (see footnotes), observations, postulated mechanisms with respect to a hypothetical melanoma-like neuromelanin (MLN) ordered in groups
of 6 aspects, and alternative mechanisms as suggested in ref [32].
* E = environmental risk, G = genetic risk, X = genetic factor but indirectly environmental risk; P = protective, F = fatal; ●●● = very strong evidence; ●● = strong
evidence; w = evidence weak. § In a group of German patients with onset of MS in childhood, studied by Hanefeld and co-workers, diverse observations were
made more or less in the same study group. Categorization for the evidence of these observations is based on comparison of p-values by multiple testing with
Bonferroni-correction as described in ref. [15].
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types of pigments have not, to our knowledge, been under-
taken. Since, however, pathological forms of eumelanins of
the skin, melanoma-like melanins, incorporate increased
amounts of iron and other metals [44-48,64], it is likely that
the presence of the hypothetical MLN would be detectable
by determining iron levels in the relevant tissues ●●. Iron
has been detected in MS plaques and it has been shown by
histopathology, three-dimensional enhanced T2*-weighted
angiography, and other forms of nuclear magnetic reson-
ance applicable to living persons, that iron is already
present in the earliest stages of demyelinating disease, al-
though iron levels showed no correlation with time elapsed
since the initial clinical event nor with the degree of disabil-
ity [65,66].
Melanins, having diverse functions, are not primarily
involved in the metabolism of reactive oxygen species
and radicals (ROS) [45] since the membranes of the two
organelles, mitochondria and melanosomes, are barriers
for the migration at least of the negatively charged ROS-
anions. Although evidence for the existence of an
equivalent of melanosome membranes in the brain is
still missing [67,68], it seems highly probable that the
contact between a substantial amount of ROS and mela-
nins results not only from an over-production and/or a
failure of the destruction of ROS in the mitochondria
but also when there is leakage of membranes that can be
induced by the ROS themselves.Melanins have the potential to act as quasi catalysts,
becoming more oxidatively charged with every redox-
reaction they participate in, so that they depend on sys-
tems for their subsequent reduction [45]. While the
normal physiological forms of these pigments transform
ROS to harmless oxygen species, abnormal oxidatively
charged forms can generate harmful longer living spe-
cies, in particular peroxynitrite ●●●.
Pathological forms of melanin, as encountered in mel-
anomas, incorporate more iron [44-48], and are thus en-
abled to interact more profoundly with radiation.
Whereas visible and ultraviolet light is transformed to
heat (photon/phonon coupling), higher energy photons
can cause photoionization which is dependent on the
Fenton reaction of iron, Table 2 [69] ●●●. Upon dissipa-
tion of the absorbed energy the pigment becomes elec-
trically and oxidatively charged [49] ●●.
Melanins can also be extremely long-lived [45] and
this could, in principle, explain the concomitance of
many factors in MS that operate over a wide range of
time, from before birth and through early and later
childhood until the onset of MS, typically in young
adults.
Environmental influences linked to the biogenesis and
behavior of MLN
The critical point in the biogenesis of MLN seems to be
a high susceptibility to peroxides of the carbon-carbon
Table 2 Five chemical reactions with supposed critical relevance in relation to MLN and MS
1 Fenton reaction of iron: (1) Fe2+ + H2O2→ Fe
3+ + HO• + OH− and (2) Fe3+ + H2O2→ Fe
2+ + HOO• + H+
This reaction can become induced by ionizing radiation/ geomagnetic disturbances and
is involved in oxidative charging of MLN (A→ B in Figure 1) [49,69]. P
2 Vitamin D-dependent γ-glutamyl-transpeptidase reaction generating glutathione in astrocytes, allowing for discharging of MLN (B→ A in
Figure 1) [35]. P
3 Radical scavenging of nitric oxide by means of uric acid [58]. P
4 Generation of peroxynitrite by a quasi-catalytical reaction of oxidatively charged MLN [45]. F
5 Demyelination by means of reaction of peroxynitrite with myelin [70]. F
P = MS protective influence, and F = fatal influence.
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ical) ortho-quinone structure in the melanin subunits
[45] and its precursors ●●● (Figure 1). Glutathione per-
oxidase as well as glutathione are needed to destroy all
peroxides and a shortage of the enzyme is related to
redox processes disturbed by syncytin-1 [9,14].
Whereas the physiological neuromelanin pigment os-
cillates between the oxidised and reduced state, a hypo-
thetical pathological form able to accumulate iron would
have a greater amplitude of charging and a tendency to
become pro-oxidatively charged (Figure 1). An oscillat-
















Figure 1 Schematic description of normal neuromelanin and melanom
5,6-dihydroxyindole-2-carboxylic acid, B: the oxidised ortho-quinone form, a
'red point symbol': iron (Fe2+). MLN has a greater tendency to become oxid
stronger blue shading.neuromelanin appears to be promoted by the combin-
ation of two equally important environmental effects,
charging triggered by geomagnetic disturbances/cosmic
radiation [1] and discharging by reduction equivalents
that must be generated by the cells in a vitamin D-
dependent manner [35] ●●●.
The possible importance of geomagnetic disturbances/
cosmic radiation is supported by a recent meta-analysis
that showed a significantly closer association of MS to
60° magnetic latitude as compared with 60° geographic
latitude [1] ●●. One consequence of this important








a-like neuromelanin (MLN). Partial structures of the subunits A:
nd C: an initial product formed upon reaction of B with H2O2;
atively charged (increased B/A-ratio) indicated in the background by
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described as biologically completely harmless. Another
consequence of this study is that vitamin D can no lon-
ger be considered as the predominant MS risk factor
[3,33], although it must still be considered to be one of
the several factors involved. Indeed this vitamin is likely
to play a key role in MS as it is involved in the gener-
ation of reduction equivalents (glutathione) in the nerve
cell, via γ-glutamyl-transpeptidase [35]. Crucially, the
oxidative charging and discharging of MLN is an oscil-
lating process, characteristic of a Belousov-Zhabotinsky
reaction [71] that could logically explain the spatial and
temporal manifestations of MS with plaques, attacks and
remissions [19].
We postulate that a pro-oxidatively charged form of
an altered melanin, namely MLN, is unable to destroy
radicals and reactive oxygen species (ROS) released
during abnormal mitochondrial activity (see below) but,
instead, transforms them to more harmful long-living
species, a process requiring nitrogen oxide (NO) as a
co-substrate. Once formed, these abnormal longer-
living species are responsible for demyelination in MS
[70] ●●●.
Underlying virological factors in the biogenesis of MLN
It is highly probable that the biogenesis of a pathologic
neuromelanin depends on a complex background
that compromises the immunological control of the
expression of an endogenous retroviral gene product,
syncytin-1 [14], as an overexpression of this cellular
component can disturb redox processes within the cell
[9] and thus favour the biosynthesis of a melanoma-like
neuromelanin (MLN). This could prove to be the link
between MLN and the characteristic patterns of
infections and associated T cell activity that we have de-
scribed in our previous publications [14,19]. The avail-
able evidence points strongly to the root cause of MS
being the overexpression of human endogenous retro-
virus W (HERV-W) ENV coding for the syncytin-1
protein consequent to a complex immunological back-
ground centered on a past infection with Epstein-Barr
virus (EBV) 005B [11,14] ●●●. In this context the ‘biog-
raphy’ of the immune system [14] is of key relevance as
an infection with EBV can compromise a MS-protective
long-lasting cellular immune surveillance only after the
immune response has been primed by other, prior,
infections, in particular with Chlamydia pneumoniae
[10,14,60] and human herpes virus 6 [21].
As a consequence, a MS-protective immune response
can become compromised ●●●. The specific candidate
targets of the involved regulatory T-cells (Tregs) and
CD8+-T-cells have been delineated [14], see also Table 1.
Tregs of critical importance for control of HERV-W ENV
expression become replaced by T-helper cells withsimilar specificity ●●●. The generation and maintenance
of the postulated HERV-W ENV suppressive and, as a
consequence MS-protective, immune surveillance on the
one hand and the replacement of Tregs by T-helper cells
on the other will inevitably have a range of observable
effects on the immune network and, thereby, on the
overall pattern of immune reactivity. These effects in-
clude an epitope spreading of the T-helper cell epitope
in EBV EBNA1 [13], an elevated antibody level against
EBNA1 [11], an attrition of the CD8+ T-cells with speci-
ficity for EBV-infected cells though not a reduction of
the total number of CD8+ T-cells with specificity for
EBV [72], and an elevated antibody production against a
diverse range of pathogens [15,16]. Those pathogens
which appear most strongly associated with the patho-
genesis of MS bear the identified candidate target
sequences for the Tregs as well as for the CD8
+ effector
T-cells on the same protein; namely, measles, varicella,
herpes simplex and rubella viruses, the latter only when
infection involves the brain, where processing of the
viral precursor protein is incomplete. All these exogen-
ous viruses support, by their involvement in the immune
network, a MS-protective cellular immune response that
becomes compromised before the clinical onset of MS.
Again, light is shed on the identity of the candidate epi-
tope of relevance for the MS-protective CD8+ T-cells by
the postulated analogy to melanoma. In both cases it is a
peptide coded for by an additional open reading frame
in the gene complex coding for the human endogenous
retroviral ENV protein [14,73]. The candidate peptide
of putative relevance for MS is, surprisingly, coded on
the counter-strand of the ENV-coding DNA strand
[14]. The candidate mechanism suppressing the
activity of HERV-W ENV but inducing a lytic cycle of
EBV [28,29,73] seems to operate by causing a shedding
of gangliosides of the neo-lacto series to the target
cell [28,29].
MLN might explain the relevant mode of action of diverse
factors in the aetiology of MS
In respect to these infective, immunological and other
potential MS risk factors, centering on epidemiological
observations, a number of questions relevant to the
MLN-based concept are raised: Could worm infestation,
which has recently been shown to have beneficial effects
in MS, be exerting a non-specific immune modulating
effect favouring expansion of sub-populations of Tregs
[22], with allergic immune reactions being counter-
productive [23] ●●●? Is a critical involvement of Tregs
evidenced by the association of MS to mutations in the
IL-7Rα gene (CD25 molecule of Tregs) [26], and the im-
portance of a long-lasting CD8+T- cell response by mu-
tations in the IL-2Rα gene [25]? Moreover, could it be
that the set of HLA-antigens of the patients [74] is less
Krone and Grange BMC Neurology 2013, 13:91 Page 8 of 11
http://www.biomedcentral.com/1471-2377/13/91able to present the peptides that have been delineated
and incriminated as essential for the relevant Tregs and
effector T-cells of the suggested MS protective immune
response [14] ●●●? Could it be that the suggested ef-
fector mechanism, a ganglioside-mediated suppression
of HERV gene expression [14,19], is reflected in a seem-
ingly protective effect of dietary n-3 polyunsaturated
linoic acids that enhance the ganglioside content of T-
cells [27]?
Other questions arise concerning additional factors
that do not predominantly involve the immune system.
Thus, could vitamin D deficiency [3,33,34] as well as a
low exposure to bright sunlight rich in UV-B resulting
in low intracellular glutathione [35] favour the biogen-
esis of MLN and play a role in a compromised ability to
reduce oxidatively charged MLN ●●●? Could a selenium
deficiency, another factor linked epidemiologically with a
risk of MS [36,37], result in reduced levels of glutathione
peroxidase (a selenium-containing enzyme) [38]? Could
smoking [40] lead to enrichment of nicotine in melanin
containing cells and thus to a disturbance of melanin
biosynthesis [41] ●●? Could the risk-enhancing influence
of female sex hormones be due to a steroid sensitivity of
the endogenous retroviral syncytin gene that has a
physiological role in the placenta [75] ●●? Moreover,
could the hormone melatonin that regulates melanin ac-
tivity explain a higher rate of MS onset and of attacks in
the lighter months of the year [31,32]?
Could psycho-physical trauma act via mitochondrial
production of ROS [52]? Could a reduction of the risk of
MS in some regions in birth cohorts since the 1920′s be
attributable to the introduction of anti-pyretics [53] and,
some time later, of antibiotics [55] with their influence
on pyogenic infections, since reactive oxygen species
and radicals (ROS) are released from mitochondria
under the influence of the unphysiological conditions of
heat and fever [54] ●●? Could it be also that the bulk of
NO in the process finally manifesting as MS is produced
by peripheral blood adherent mononuclear cells in small
blood vessels that can still be seen in the plaques as the
pathological end stages of MS [57] ●●? The more harm-
ful nitrogen-containing ROS such as peroxynitrite, able
to cause demyelination, can, however, be scavenged by
uric acid [58] ●●. Interestingly, in this context, MS is ex-
tremely rare in patients with gout and the serum con-
centration of uric acid tends to be about 10-15% lower
in MS patients than in controls [58]. Could a currently
used MS remedy, glatiramer acetate, work predomin-
antly as an inhibitor of NO synthases [59]? Finally, light
might be shed on what is perhaps the least understood
aspect of MS, the question of what is going wrong with
the mitochondria and why they have a higher tendency
to produce ROS? It has been postulated that there is an
activation of the cellular mevalonate pathway in MS withproduction of endogenous digoxin and a decrease of
ubiquitin levels that impairs mitochondrial function and
contributes to oxidative stress [56]. The question is
raised whether this aberrant mitochondrial function
might be caused by abnormal expression and activity of
HERVs [76].
Discussion
The melanin-based concept is a promising and unifying
one that could explain several of the enigmas of MS, in-
cluding the distribution of age at onset since there is
only a very small amount of neuromelanin in childhood,
in particular in early childhood [45], and also the com-
plex basis of latency and the Belousov-Zhabotinsky char-
acteristic of the spatial and temporal characteristics of
the disease (plaques, attacks, remissions) [19,71]. Al-
though many putative factors appear to be involved at
the various states of the pathogenesis and clinical mani-
festation of MS, the generation and maintenance of
MLN is, if the hypothesis is correct, likely to be a key
feature throughout. Moreover, the concept sheds light,
in principle, on a number of epidemiological observa-
tions on factors possibly involved in the aetiology of MS,
in particular EBV infection, the HLA system, geomag-
netic disturbances/cosmic radiation, vitamin D levels,
and smoking, as well as several others listed in Table 1.
The possible involvement of cosmic radiation [77,78] is
an aspect in which interest has been revived [1] and it
has been investigated recently in a mouse model of
Alzheimer’s disease [79]. Although definitive answers
cannot be given to any of the many specific questions
raised on possible relations to the hypothetical MLN, it
should be noted that the concept as a whole is unique
amongst the hypotheses on MS in not contradicting the
birth cohort trends [2]. Also, as the many factors re-
ferred to above vary from region to region and from pa-
tient to patient, the involvement of MLN could be a
constant feature despite the heterogeneous nature of the
disease.
The concept discussed in this debate paper differs
markedly from competing hypotheses and from current
concepts that are focused on cell-mediated immune re-
actions directed against myelin. In this context, infiltrat-
ing lymphocytes are typically absent in progressing and
expanding MS lesions, and there is a prominent oligo-
dendrocyte loss and apoptosis, supporting the concept
that the plaque formation has indeed some basis other
than cell-mediated immunity against a myelin or oligo-
dendrocyte antigen [80,81]. From this concept, and from
the conclusions of other workers [82], it now appears
that autoimmune reactions in MS are only secondary
phenomena.
The unifying concept has many elements that may
vary in their impact from patient to patient. Though less
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vance more for secondary phenomena, such as auto-
immune reactions and phenomena associated with the
compartmentalisation of iron. Thus the accumulation of
iron in MLN may result in a shortage of iron in myelin,
which could impair the function of nerve cells [83].
These effects might contribute to the heterogeneity of
the clinical manifestations of MS ●●.
There is certainly a need to study all the diverse as-
pects of MS in relation to MLN and iron, including the
impact of pregnancy [39] and geological terrain of resi-
dence [50]. Unfortunately, neuromelanin is not a mol-
ecule that is easily studied [43], especially as there is
little or no neuromelanin (the precursor of MLN) in the
animals used for experimental models in MS [45] ●●●.
Thus, perhaps, emphasis must be placed on the study on
iron in the human brain [84] ●●. While prevention of
MS may ultimately depend on the development of an ef-
fective vaccine against the Epstein-Barr virus that can be
administered in early childhood, as the sine qua non for
the disease is Epstein-Barr virus infection [14,72] ●●●,
therapy of established MS poses a greater challenge. Ad-
dressing this challenge would be greatly facilitated if
there is indeed a unifying factor underlying the complex-
ity of the pathogenesis of MS and we open for debate
the possibility that this unifying factor is the generation
of a melanoma-like neuromelanin.
Summary
The concept of an abnormal MLN explains many of the
characteristics of MS and we postulate that it is an es-
sential feature of this disease. There are many outstand-
ing unanswered questions surrounding the various
pathological, immunological and clinical aspects of MS
but a consideration of the underlying role of MLN and
the processes leading to its generation and maintenance
may help to answer these questions and pave the way to
a unified concept of the pathogenesis of this complex
disease.
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